Search

everythinglearnresearchcommunity

for

Search:↓

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

New progesterone-based compounds can block male hormones.

Certain finger length ratios and body hair patterns may predict side effects from birth control pills in women.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

A new, safer method to make finasteride from progesterone is effective for industrial use.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

New compounds may help treat prostate issues without affecting androgen receptors.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

Congenital Adrenal Hyperplasia is mainly caused by enzyme deficiencies, leading to varying symptoms like hormone imbalances and physical changes.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

Male cells need DHT to respond to testosterone, while female cells do not.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.